Cargando…
Safety of SARS‐CoV‐2 vaccines in psoriatic patients treated with biologics: A real life experience
Vaccination is the most effective method to prevent and control the SARS‐CoV‐2 infection and biologics are not considered a contraindication for vaccination. The burning question is that safety data are lacking since patients taking drugs affecting the immune system were excluded from clinical trial...
Autores principales: | Musumeci, Maria Letizia, Caruso, Giuliana, Trecarichi, Andrea Calogero, Micali, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646328/ https://www.ncbi.nlm.nih.gov/pubmed/34699117 http://dx.doi.org/10.1111/dth.15177 |
Ejemplares similares
-
Psychopathological Variables and Sleep Quality in Psoriatic Patients
por: Luca, Maria, et al.
Publicado: (2016) -
Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis
por: Klavdianou, Kalliopi, et al.
Publicado: (2020) -
Safety and Impact of Anti-COVID-19 Vaccines in Psoriatic Patients Treated with Biologics: A Real Life Experience
por: Skroza, Nevena, et al.
Publicado: (2021) -
Safety and efficacy of molnupiravir in SARS‐CoV‐2‐infected patients: A real‐life experience
por: De Vito, Andrea, et al.
Publicado: (2022) -
Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR kit 1.0 for the detection of SARS-CoV-2
por: Di Carlo, Daniele, et al.
Publicado: (2021)